ADVFN - Advanced Financial Network.
HOME» NYSE » B » BCR Stock Price » BCR Stock News

Bard C R Share News

 Bard (c.r.), Inc. Stock Price
BCR Stock Price
 Bard (c.r.), Inc. Stock Chart
BCR Stock Chart
 Bard (c.r.), Inc. Stock News
BCR Stock News
 Bard (c.r.), Inc. Company Information
BCR Company Information
 Bard (c.r.), Inc. Stock Trades
BCR Stock Trades

CR Bard Financial Chief Schermerhorn To Retire

DOW JONES NEWSWIRES Medical-device maker C.R. Bard Inc. (BCR) disclosed a change in a top post Monday, announcing the retirement of its chief financial officer after more than 25 years with the company. Todd C. Schermerhorn joined the company in 1985 as a financial analyst. He has served in various positions throughout his tenure, including controller of the vascular systems division. He stepped into the chief financial post in 2003. "Todd's leadership has been invaluable to Bard in shaping our strategy and culture. His tireless commitment and passion for excellence have influenced our organization across every function and at every level," said Chief Executive Timothy M. Ring. The company didn't name an immediate successor, instead noting that Schermerhorn will stay on for a transition period and serve as chief financial officer until a successor is elected. A rebound in spending in the health-care sector has driven renewed profits at companies like C.R. Bard, which has reported solid revenue growth on a strong performance in the vascular business, its largest by revenue. Last month, the company reported it swung to a second-quarter loss as a hefty charge related to a legal settlement masked revenue growth across all product categories. Shares of C.R. Bard rose 69 cents to $99.37 recently. The stock is up about 8.2% since the start of the year. -By Mia Lamar, Dow Jones Newswires; 212-416-3207; mia.lamar@dowjones.com

Stock News for Bard C R (BCR)
DateTimeHeadline
11/15/201308:47:28ValueAct Capital Management LP 3Q 13F: Holdings As Of Sep 30
11/15/201308:18:57Farallon Capital Management 3Q 13F: Largest Eliminations
11/15/201308:18:52Farallon Capital Management 3Q 13F: Holdings As Of Sep 30
11/15/201307:07:30Two Sigma Investments 3Q 13F: Largest Eliminations
11/15/201307:07:27Two Sigma Investments 3Q 13F: Largest Sales
11/15/201307:07:27Two Sigma Investments 3Q 13F: Largest Purchases
11/15/201307:07:27Two Sigma Investments 3Q 13F: Largest Eliminations -2-
11/15/201307:04:50Bridgewater Associates LP 3Q 13F: Largest -2-
11/15/201307:04:50Bridgewater Associates LP 3Q 13F: Holdings As Of -2-
11/15/201307:04:50Bridgewater Associates LP 3Q 13F: Largest Purchases
11/15/201307:04:49Bridgewater Associates LP 3Q 13F: Holdings As Of Sep 30
09/04/201309:35:09U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
06/28/201310:54:22Boston Scientific to Buy C.R. Bard Unit for $275 Million
10/25/201218:32:16High-Grade-Bond Market Absorbs $3.9 Billion of New Deals
06/05/201212:53:24J&J to Stop Selling Surgical Mesh Amid Lawsuits, Concerns -AP
04/21/201200:20:37MARKET SNAPSHOT: U.S. Stock Gains Hinge On Apple, Blue-chip Results
01/04/201216:13:14FDA Orders Post-Market Testing Of Surgical Mesh Amid Safety Concerns
12/21/201109:10:36US Stock Futures: HOT STOCKS TO WATCH
10/26/201107:57:35US Stock Futures Higher On Optimism Ahead Of EU Summit
09/14/201114:52:55Erste Group Bank To Buy 24.12% Stake In Romania Unit

Bard C R and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad